Načítá se...
PCSK9: From Basic Science Discoveries to Clinical Trials
Unknown fifteen years ago, proprotein convertase subtilisin/kexin type 9 (PCSK9) is now common parlance amongst scientists and clinicians interested in prevention and treatment of atherosclerotic cardiovascular disease. What makes this story so special is not its recent discovery nor the fact that i...
Uloženo v:
| Vydáno v: | Circ Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976255/ https://ncbi.nlm.nih.gov/pubmed/29748367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.118.311227 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|